Alpenglow Biosciences Partners with PathNet to Commercialize 3D Microscope Tech for Cancer Diagnostics with $250K Funding

Seattle-based Alpenglow Biosciences partnered with PathNet to commercialize its 3D microscope technology for cancer diagnostics, focusing on prostate and bladder cancers. The startup also secured $250,000 in funding from Mike Rice to support regulatory validation and clinical application development.

No comments yet.